These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14983807)

  • 21. Experience with daptomycin in an infectious diseases service over 1 year: utility in an outpatient parenteral antibiotic programme.
    Seaton RA; Macconnachie AA
    Int J Antimicrob Agents; 2008 May; 31(5):492-7. PubMed ID: 18313274
    [No Abstract]   [Full Text] [Related]  

  • 22. Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
    Wesson KM; Lerner DS; Silverberg NB; Weinberg JM
    Dis Mon; 2004 Jul; 50(7):395-406. PubMed ID: 15280870
    [No Abstract]   [Full Text] [Related]  

  • 23. [Daptomycin. Reassessment of an antibiotic].
    Gobernado M
    Rev Esp Quimioter; 2007 Mar; 20(1):11-8. PubMed ID: 17530032
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic challenges in the era of antibiotic resistance.
    Lee C
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
    Kanafani ZA; Corey GR
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with daptomycin: bacteraemia and endocarditis.
    Levine DP
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with recently approved antibiotics.
    Paterson DL
    Curr Opin Pharmacol; 2006 Oct; 6(5):486-90. PubMed ID: 16904377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.
    Owens RC; Lamp KC; Friedrich LV; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S6-12. PubMed ID: 17904950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The second life of daptomycin: analysis of a successful come-back].
    Decousser JW; Doucet Populaire F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
    [No Abstract]   [Full Text] [Related]  

  • 30. Serious staphylococcal infections--cyclic lipopeptides: meeting new challenges.
    Graninger W
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():1-2. PubMed ID: 18226083
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
    Skiest DJ
    J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new in star in antibiotic heaven--daptomycin].
    Holzgrabe U
    Pharm Unserer Zeit; 2004; 33(4):270. PubMed ID: 15287683
    [No Abstract]   [Full Text] [Related]  

  • 35. Daptomycin.
    Prescrire Int; 2007 Dec; 16(92):245. PubMed ID: 18095389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
    Munoz-Price LS; Lolans K; Quinn JP
    Clin Infect Dis; 2005 Aug; 41(4):565-6. PubMed ID: 16028170
    [No Abstract]   [Full Text] [Related]  

  • 37. [Enterococcus faecalis endocarditis successfully treated with daptomycin].
    Bonnet E
    Med Mal Infect; 2008 Dec; 38 Spec No 2():4-6. PubMed ID: 19185201
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of antibiotics in dermatologic surgery.
    Robins P; Hsiung S
    J Drugs Dermatol; 2006 Sep; 5(8):780-2. PubMed ID: 16989193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.